Core--Protein modulators of toxicity
Core--Protein modulators of toxicity
批准号:
6576566
负责人:
Thomas A Gasiewicz
金额:
$22.85万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-04-01 至 2003-03-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The research activities in the Core emphasize biologically
active proteins that function as critical regulatory molecules in normal cell
processes. These research projects are making contributions toward
understanding risk associated with exposures to particular chemicals and to
knowledge of the molecular and cellular processes involved in certain
diseases. Several sub-themes are included under this central theme: Receptor
proteins as molecular sensors, post-transcriptional modification of RNA,
proteins involved in Glutathione homeostasis and the role of these in
xenobiotic transport and metabolism, and proteins involved in cell cycle
regulation as targets for xenobiotics.
The investigations are organized into seven projects: 1) Cellular and
Molecular Responses to Dioxins Mediated by the Ah Receptor (T. A. Gasiewicz).
This project is directed at understanding the molecular and cellular basis by
which the Ah receptor mediates the toxicity of structurally-related
halogenated hydrocarbons. A secondary objective is to advance knowledge of Ah
receptor function especially the role of AhR phosphorylation. Collaborative
projects include studies using an AhR-responsive reporter mouse model and
molecular actions of AhR and cellular and functional alterations in the immune
system. 2) Causes and Consequences of Thymic Atrophy Induced by TCDD and
Estrogens (A. E. Silverstone). A major objective of this work is the
identification of the cell type(s) that contain the estrogen receptor (ER) and
AhR and are activated by TCDD or estrogen to cause thymic atrophy and
immunosuppression. These studies will examine either cell cycle arrest,
apoptosis, and/or altered cellular differentiation are involved and
identification of the gene products involved. A second objective is to use a
mouse model of a lupus-like nephritis to identify estrogen and TCDD-induced
alterations in T-cell development. 3) Cellular and Molecular Toxicology of
Heme Degradation (M. Maines). This research focuses on the heme metabolic
pathway enzymes, heme oxygenase (HO) and biliverdin reductase (BVR) to
elucidate the physiological functions of the heme degradation products. These
studies are examining the biological functions of HO in the brain and
cardiovascular system. One hypothesis being tested is that modulation of HO
activity by exogenous and endogenous sensors may be involved in steroid-mediated
degradation of neurons in brain areas involved in memory and
learning. Other studies indicate that CO generated via HO may be a component
of the cardiovascular system defense against impairment induced by nephrotoxic
agents. The role of BVR as a defense mechanism against oxidants in the brain.
4) Alteration in RNA processing by Alcohol and its Role in Atherogenic
Diseases (H. Smith). This research involves the purification and molecular
cloning of auxiliary protein genes involved in RNA editing. Additional
studies are testing the hypothesis that ethanol stimulation of apoB mRNA
editing results from alteration of enzymes/factors involved in mRNA editing,
5) Glutathione-dependent Metabolism and Plasma Membrane Transport of
Xenobiotics (N. Ballatori). The focus of this research is the identification
and characterization of cell membrane proteins that mediate the export of GSH
adducts, related organic anions and GSH. This group has shown that oatp1, a
sinusoidal organic solute transporter in liver functions as a GSH/organic
solute exchanger and elucidates a pathway for GSH release in blood plasma.
Other studies are defining the role of the y-glutamyl cycle in a mercapturic
acid biosynthesis. N-acetylcysteine has been identified as an antidote for
methyl mercury. 6) Bioactivation of Halogenated Hydrocarbons (M. W. Anders).
A major objective of this research is to investigate the GSH-dependent
bioactivation of haloalkanes and the GSH- and b-lyase-dependent bioactivation
of haloalkenes. Mechanisms of cysteine S-conjugate induced cytotoxicity and
activation of transcription factors in response to changes in cellular redox
as a possible step is being considered. The role of mitochondria as an
intracellular target is being assessed. 7) Radiation Sensitivity and G2M
Delay in Lung Tumor Cells (P. Keng). The central hypothesis to be tested is
that IFN-b modulates DNA repair capacity of irradiated human lung tumor cells.
The repair of DNA strand breaks is the focus of these studies and the impact
of IFN-b on accumulation of cells in G2M following irradiation is being
investigated.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Signaling Pathway in Ah Receptor-Dependent Control of Hematopoietic Stem Cells
-
批准号:8556514
-
项目类别:
-
资助金额:$33.98万
-
财政年份:2013
-
负责人:Thomas A Gasiewicz
-
依托单位:
Signaling Pathway in Ah Receptor-Dependent Control of Hematopoietic Stem Cells
-
批准号:8711463
-
项目类别:
-
资助金额:$34.19万
-
财政年份:2013
-
负责人:Thomas A Gasiewicz
-
依托单位:
Strategic Vision & Impact on Environmental Health
-
批准号:8245860
-
项目类别:
-
资助金额:$14.71万
-
财政年份:2011
-
负责人:Thomas A Gasiewicz
-
依托单位:
EGCG Has Anti-prostate Cancer Activity by Inhibiting hsp90
-
批准号:8189491
-
项目类别:
-
资助金额:$22.79万
-
财政年份:2011
-
负责人:Thomas A Gasiewicz
-
依托单位:
EGCG Has Anti-prostate Cancer Activity by Inhibiting hsp90
-
批准号:8332788
-
项目类别:
-
资助金额:$19.12万
-
财政年份:2011
-
负责人:Thomas A Gasiewicz
-
依托单位:
Center Director
-
批准号:8245862
-
项目类别:
-
资助金额:$5.23万
-
财政年份:2011
-
负责人:Thomas A Gasiewicz
-
依托单位:
A Role of the Ah Receptor in Hematopoiesis: Model Characterization
-
批准号:7763260
-
项目类别:
-
资助金额:$7.62万
-
财政年份:2009
-
负责人:Thomas A Gasiewicz
-
依托单位:
A Role of the Ah Receptor in Hematopoiesis: Model Characterization
-
批准号:7581310
-
项目类别:
-
资助金额:$7.7万
-
财政年份:2009
-
负责人:Thomas A Gasiewicz
-
依托单位:
An Endogenous Ah Receptor Ligand: Gene and Physiological Responses
-
批准号:7293745
-
项目类别:
-
资助金额:$19.25万
-
财政年份:2007
-
负责人:Thomas A Gasiewicz
-
依托单位:
An Endogenous Ah Receptor Ligand: Gene and Physiological Responses
-
批准号:7487558
-
项目类别:
-
资助金额:$22.64万
-
财政年份:2007
-
负责人:Thomas A Gasiewicz
-
依托单位:
EGCG Inhibits AhR and Carcinogenesis by Modulating Hsp90
-
批准号:7014379
-
项目类别:
-
资助金额:$19.5万
-
财政年份:2006
-
负责人:Thomas A Gasiewicz
-
依托单位:
EGCG Inhibits AhR and Carcinogenesis by Modulating Hsp90
-
批准号:7229822
-
项目类别:
-
资助金额:$22.72万
-
财政年份:2006
-
负责人:Thomas A Gasiewicz
-
依托单位:
Core--Community Outreach and Education Program
-
批准号:6868523
-
项目类别:
-
资助金额:$16.3万
-
财政年份:2005
-
负责人:Thomas A Gasiewicz
-
依托单位:
Administrative Core
-
批准号:6868521
-
项目类别:
-
资助金额:$28.55万
-
财政年份:2005
-
负责人:Thomas A Gasiewicz
-
依托单位:
Core--University facilities
-
批准号:6576569
-
项目类别:
-
资助金额:$22.85万
-
财政年份:2002
-
负责人:Thomas A Gasiewicz
-
依托单位:
Core--University facilities
-
批准号:6495635
-
项目类别:
-
资助金额:$22.85万
-
财政年份:2001
-
负责人:Thomas A Gasiewicz
-
依托单位:
Core--Protein modulators of toxicity
-
批准号:6441457
-
项目类别:
-
资助金额:$12.06万
-
财政年份:2001
-
负责人:Thomas A Gasiewicz
-
依托单位:
Core--Protein modulators of toxicity
-
批准号:6495632
-
项目类别:
-
资助金额:$22.85万
-
财政年份:2001
-
负责人:Thomas A Gasiewicz
-
依托单位:
Core--University facilities
-
批准号:6441460
-
项目类别:
-
资助金额:$12.06万
-
财政年份:2001
-
负责人:Thomas A Gasiewicz
-
依托单位:
Core--University facilities
-
批准号:6361482
-
项目类别:
-
资助金额:$12.06万
-
财政年份:2000
-
负责人:Thomas A Gasiewicz
-
依托单位: